Pages that link to "Q35551304"
Jump to navigation
Jump to search
The following pages link to Strengths and limitations of commercial tests for hepatitis C virus RNA quantification (Q35551304):
Displaying 17 items.
- Structure, stability and behaviour of nucleic acids in ionic liquids (Q27001036) (← links)
- Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5 (Q27473038) (← links)
- Comparison of Performance Characteristics of Three Real-Time Reverse Transcription-PCR Test Systems for Detection and Quantification of Hepatitis C Virus (Q27481004) (← links)
- A Novel Diagnostic Target in the Hepatitis C Virus Genome (Q27487878) (← links)
- Performance of the Abbott Real-Time PCR Assay Using m2000sp and m2000rt for Hepatitis C Virus RNA Quantification (Q27488563) (← links)
- Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C (Q27490792) (← links)
- Processes to manage analyses and publications in a phase III multicenter randomized clinical trial (Q33694159) (← links)
- Coffee Consumption Is Associated With Response to Peginterferon and Ribavirin Therapy in Patients With Chronic Hepatitis C (Q35027939) (← links)
- Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials (Q36188710) (← links)
- Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (Q37156650) (← links)
- Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C. (Q37397022) (← links)
- Rational design of DNA sequences for nanotechnology, microarrays and molecular computers using Eulerian graphs (Q37509316) (← links)
- Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection (Q37511219) (← links)
- Use of the MagNA pure LC automated nucleic acid extraction system followed by real-time reverse transcription-PCR for ultrasensitive quantitation of hepatitis C virus RNA (Q39989744) (← links)
- HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial (Q43001559) (← links)
- Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method (Q43037979) (← links)
- Biological and nanotechnological applications using interactions between ionic liquids and nucleic acids. (Q53692197) (← links)